Medication info
Glymepride Tablet 2 mg (Glymepride)

Glymepride Tablet 2 mg (Glymepride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
HLB Pharma Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 201307853 · Approved 2013.06.26 · Insurance code 647302680

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit from doses greater than 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this drug with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered drug. 4) Dose adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after successful initial management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may be increased. Appropriate caution should be exercised.

Ingredients

Manufacturer
HLB Pharma Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It acts as an adjunct to diet and exercise therapy and can also be used alone. If blood sugar control is inadequate with monotherapy, it can be used in combination with oral hypoglycemic agents or insulin. Especially when sufficient control is difficult with monotherapy of sulfonylureas or metformin, it is used in combination with metformin. By utilizing it in multiple ways, it helps effectively control blood sugar and prevent complications of diabetes.

How to take

Adult dose

Adjust individually for each patient. Swallow without chewing with at least 1/2 cup of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, there is little additional benefit from doses greater than 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this drug with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this drug There is no precise dose equivalence between this drug and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this drug, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered drug. 4) Dose adjustment While taking this drug, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur after successful initial management during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this drug with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this drug is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may be increased. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or those in diabetic ketoacidosis or coma. It is also not recommended for those who have had an allergic reaction to this medication or sulfonylureas, or those with severe liver or kidney dysfunction. Women who are pregnant, possibly pregnant, or breastfeeding should avoid taking this medication. Patients with severe infections, or those before and after surgery, or with major trauma should be recommended insulin therapy instead of this medication. Care should be taken when gastrointestinal disturbances such as diarrhea or vomiting occur, as absorption may be impaired, leading to a risk of hypoglycemia. This medication contains lactose, so those with lactose intolerance or specific genetic metabolic disorders should not take it. In the initial dosing phase, the risk of hypoglycemia is high, so blood sugar and symptoms should be closely monitored, especially in the elderly, those with irregular meals, poor nutritional status, or weak kidney or liver function. Blood sugar control may vary with alcohol consumption or other medications, so be sure to inform healthcare professionals about any other medications or health conditions during treatment. Symptoms of hypoglycemia include headaches, severe hunger, dizziness, confusion, drowsiness, and decreased consciousness; if these symptoms occur, immediate intake of sugar or consultation with healthcare professionals is necessary. This medication may cause various side effects such as visual disturbances, gastrointestinal symptoms, liver function abnormalities, blood abnormalities, and allergic reactions. If any unusual symptoms occur, it is essential to consult a doctor immediately. For blood sugar control, regular meals, exercise, and weight management are important. It is necessary to maintain these lifestyle habits while taking this medication. During pregnancy or breastfeeding, it may be harmful to the fetus or newborn, so insulin therapy is recommended instead of this medication. This medication is not used in children under 18, as safety and efficacy have not been confirmed. Severe hypoglycemia may occur in case of overdose, so immediate medical attention is required if an overdose occurs. This medication should be stored out of reach of children and kept in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, reduced concentration, decreased agility or motivation, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, altered liver function, biliary secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, altered liver function, abdominal pain, arthralgia, indigestion, facial edema, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent air or moisture from entering. The appropriate storage temperature is room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.